Security Snapshot

KAZIA THERAPEUTICS LTD - American Depositary Shares (KZIA) Institutional Ownership

CUSIP: 48669G105

13F Institutional Holders and Ownership History from Q4 2017 to Q1 2025

Latest Period

n/a

Institutions Reporting

Shares (Excl. Options)

Price

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Shares outstanding
11,430,535
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors

Key facts

  • KZIA - KAZIA THERAPEUTICS LTD - American Depositary Shares is tracked under CUSIP 48669G105.
  • Latest finished 13F holder period is not available.
  • 3 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 0 to 0 between Q4 2024 and Q1 2025.
  • SEC-reported value moved from $0 to $0.

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Schedule 13D/G

Ownership context comes from Schedule 13D/G and available holder history for this CUSIP.

Open SEC evidence

Security key

48669G105

Latest holder period

n/a

13F holders

13D/G owners

3

CIK / CUSIP context first

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
3
Security
KZIA
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Chernett Jorey 18% +33% 2,114,649 +33% Chernett Jorey 26 May 2026
Alumni Capital LP 10% 0% 178,591 -77% Alumni Capital LP 31 Jul 2025
Dauntless Investment Group, LLC 0% -99% 1 -100% Dauntless Investment Group, LLC 31 Dec 2025

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
30
Latest
n/a
Rows shown
1-25 of 30
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q1 0 $0 -$215 0
2024 Q4 0 $0 -$915,427 0
2024 Q3 2,129,596 $915,427 +$790,699 $0.43 16
2024 Q2 391,517 $89,517 -$8,321 $0.23 11
2024 Q1 371,232 $115,509 -$1,994,451 $0.31 11
2023 Q4 4,883,338 $2,151,708 +$2,045,684 $0.44 17
2023 Q3 237,143 $235,867 -$50,263 $1.00 10
2023 Q2 284,444 $327,598 +$11,438 $1.16 9
2023 Q1 271,491 $279,385 -$133,640 $1.03 8
2022 Q4 426,146 $262,014 -$39,908 $0.61 9
2022 Q3 480,663 $527,000 +$2,168 $1.10 6
2022 Q2 294,297 $1,235,000 -$433,172 $4.20 10
2022 Q1 375,986 $2,896,000 -$805,894 $7.86 10
2021 Q4 475,552 $4,007,000 +$165,915 $8.43 10
2021 Q3 539,906 $5,029,362 +$81,288 $11.33 14
2021 Q2 536,161 $4,344,316 +$396,634 $9.87 12
2021 Q1 467,061 $4,601,637 -$368,945 $12.39 12
2020 Q4 529,082 $3,747,276 +$1,082,695 $8.64 12
2020 Q3 442,094 $2,314,216 +$887,634 $6.75 10
2020 Q2 309,803 $723,108 +$170,070 $3.35 6
2020 Q1 260,799 $472,093 +$31,229 $2.90 6
2019 Q4 249,972 $670,139 -$8,525 $4.34 7
2019 Q3 253,418 $568,120 +$72,875 $3.75 7
2019 Q2 227,122 $324,083 +$51,992 $2.42 7
2019 Q1 205,065 $365,107 -$27,520 $3.34 5
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .